H3K18la enhances NFκB signaling, and facilitates the senescence-associated secretory phenotype (SASP) components IL-6 and IL-8, thereby promoting AD progression through inflammatory signaling pathways [31]. Here, NFKB1 is linked to Alzheimer disease.